Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation. [electronic resource]
- Immunology and cell biology Aug 2015
- 662-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1440-1711
10.1038/icb.2015.21 doi
Animals CD4-Positive T-Lymphocytes--cytology Chromones--pharmacology Interleukin-17--biosynthesis Lymphopoiesis--drug effects MAP Kinase Signaling System--drug effects Mice Mice, Inbred C57BL Morpholines--pharmacology Phosphatidylinositol 3-Kinases--physiology Phosphorylation--drug effects Protein Kinase Inhibitors--pharmacology Protein Processing, Post-Translational--drug effects Protein Serine-Threonine Kinases--antagonists & inhibitors Proto-Oncogene Proteins c-akt--physiology Receptor, Transforming Growth Factor-beta Type I Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta--antagonists & inhibitors Signal Transduction--drug effects Sirolimus--pharmacology Smad Proteins--physiology T-Lymphocytes, Regulatory--cytology TOR Serine-Threonine Kinases--physiology Th17 Cells--cytology Transforming Growth Factor beta--physiology